Similarly, Luteolin, was known to suppress the stemness of prostate cancer cells by inhibiting the Wnt signaling via transcriptional upregulation of frizzle class receptor 6 (FZD6) (Li et al., 2018). The gene discussed is FZD6; the disease is prostate carcinoma.